Simona King - 10 Feb 2022 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Financial Officer
Signature
/s/ Edgar Cale, Attorney-in Fact
Issuer symbol
PASG
Transactions as of
10 Feb 2022
Net transactions value
$0
Form type
4
Filing time
14 Feb 2022, 16:05:01 UTC
Previous filing
25 Aug 2021
Next filing
20 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Stock Option (right to buy) Award $0 +159,000 $0.000000 159,000 10 Feb 2022 Common Stock 159,000 $4.52 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.